Suppr超能文献

罗马尼亚蒂米什瓦拉一家重症监护病房收治的新冠肺炎患者的细菌和真菌二重感染

Bacterial and Fungal Superinfections in COVID-19 Patients Hospitalized in an Intensive Care Unit from Timișoara, Romania.

作者信息

Novacescu Alexandru Noris, Buzzi Bettina, Bedreag Ovidiu, Papurica Marius, Rogobete Alexandru Florin, Sandesc Dorel, Sorescu Teodora, Baditoiu Luminita, Musuroi Corina, Vlad Daliborca, Licker Monica

机构信息

Doctoral School, 'Victor Babes' University of Medicine and Pharmacy, Timisoara, Romania.

Compartment of Anesthesia and Intensive Care, 'Dr. Victor Babes' Infectious Diseases and Pulmonology Clinical Hospital, Timisoara, Romania.

出版信息

Infect Drug Resist. 2022 Dec 1;15:7001-7014. doi: 10.2147/IDR.S390681. eCollection 2022.

Abstract

PURPOSE

Critically ill patients hospitalized in the intensive care unit (ICU) have an increased infection risk. The aim of this study was to determine the bacterial and fungal superinfections rate in Coronavirus disease 2019 (COVID-19) patients stationed in the ICU, identify risk factors associated with their development and to determine whether superinfection plays a role in patients' outcome in this population.

PATIENTS AND METHODS

In this retrospective, non-interventional, single centre, cohort study, medical records of 302 consecutive patients with SARS-COV-2 pneumonia admitted into the COVID-19 ICU of the largest university hospital from Western Romania between October 2020 and May 2021, were reviewed, of whom 236 patients met the inclusion criteria.

RESULTS

One hundred and nineteen patients developed a superinfection ≥48 h after being admitted to the hospital. Superinfection rate in the ICU was 50.42%. Coagulase-negative Staphylococci (CoNS) and spp. were predominantly isolated from blood cultures, while and spp. from tracheobronchial aspirates. Significant independent risk factors regarding bacterial/fungal superinfection in COVID-19 patients were obtained for the following variables: number of days of central venous catheter (HR = 1.13 [1.07-1.20], p < 0.001) and prior administration of corticosteroids (HR = 2.80 [1.33-5.93], p = 0.007). Four independent predictive risk factors were associated with unfavorable outcome: age (HR = 1.07 [95% CI 1.03-1.12], p = 0.001); Carmeli Score (HR = 6.09 [1.18-31.50], p = 0.031); body mass index (HR = 1.11 [1.02-1.21], p = 0.011) and the presence of a central venous catheter (HR = 6.49 [1.93-21.89], p = 0.003).

CONCLUSION

The superinfection rate in COVID-19 patients was high in this study group. Exogenous risk factors were associated with superinfection more than endogenous factors. Only a small percentage of uninfected COVID-19 patients were not prescribed antibiotics during their hospitalization, raising serious concerns regarding the judicious prescribing of antibiotics in viral infections.

摘要

目的

入住重症监护病房(ICU)的重症患者感染风险增加。本研究的目的是确定入住ICU的2019冠状病毒病(COVID-19)患者的细菌和真菌二重感染率,识别与其发生相关的危险因素,并确定二重感染是否在该人群患者的预后中起作用。

患者与方法

在这项回顾性、非干预性、单中心队列研究中,对2020年10月至2021年5月间罗马尼亚西部最大大学医院COVID-19 ICU收治的302例连续的严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)肺炎患者的病历进行了回顾,其中236例患者符合纳入标准。

结果

119例患者在入院≥48小时后发生二重感染。ICU中的二重感染率为50.42%。凝固酶阴性葡萄球菌(CoNS)和 种主要从血培养中分离出来,而 种和 种从气管支气管吸出物中分离出来。关于COVID-19患者细菌/真菌二重感染的显著独立危险因素如下变量:中心静脉导管留置天数(HR = 1.13 [1.07 - 1.20],p < 0.001)和先前使用皮质类固醇(HR = 2.80 [1.33 - 5.93],p = 0.007)。四个独立的预测危险因素与不良预后相关:年龄(HR = 1.07 [95% CI 1.03 - 1.12],p = 0.001);卡梅利评分(HR = 6.09 [1.18 - 31.50],p = 0.031);体重指数(HR = 1.11 [1.02 - 1.21],p = 0.011)和中心静脉导管的存在(HR = 6.49 [1.93 - 21.89],p = 0.003)。

结论

本研究组中COVID-19患者的二重感染率很高。外源性危险因素比内源性因素与二重感染的关联更大。只有一小部分未感染的COVID-19患者在住院期间未使用抗生素,这引发了对病毒感染中抗生素合理使用的严重担忧。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b61b/9721122/1fb2a85d9ed6/IDR-15-7001-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验